Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...
The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...
Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...
As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels of flu and RSV activity in wastewater. In emergency room visits, the CDC ...
Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...